Potential therapeutical effects of topical halofuginone hydrobromide in keloid management

Med Hypotheses. 2007;69(3):707. doi: 10.1016/j.mehy.2007.01.009. Epub 2007 Feb 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Topical
  • Cell Proliferation
  • Gene Expression Regulation, Enzymologic
  • Humans
  • Keloid / drug therapy*
  • Matrix Metalloproteinase 2 / metabolism
  • Models, Biological
  • Models, Theoretical
  • Piperidines / administration & dosage*
  • Piperidines / therapeutic use*
  • Protein Synthesis Inhibitors / administration & dosage*
  • Protein Synthesis Inhibitors / therapeutic use*
  • Quinazolinones / administration & dosage*
  • Quinazolinones / therapeutic use*

Substances

  • Piperidines
  • Protein Synthesis Inhibitors
  • Quinazolinones
  • Matrix Metalloproteinase 2
  • halofuginone